Blood Screening Market Size, Share, Trends & Forecast

The Blood Screening Market is expanding as blood banks and healthcare organizations invest in technologies designed to improve the safety and efficiency of donated blood testing. According to Market Research Future, the market was valued at USD 3.46 billion in 2025 and is projected to reach USD 8.19 billion by 2035, registering a CAGR of 9.0% from 2026 to 2035.

Stricter regulatory requirements are an important factor supporting market development. Blood centers are increasingly focused on individual donor risk assessment and comprehensive screening, creating demand for upgraded testing infrastructure. Rising blood donation volumes are also expanding the number of units that require screening before entering the healthcare supply chain.

Technology modernization is further strengthening demand. Integrated screening platforms are increasingly replacing fragmented workflows, while automated systems can support high-volume testing environments. The report indicates that instruments are expected to be the fastest-growing product segment, with a projected 10.6% CAGR through 2035.

Reagents and kits remain a major source of market revenue, accounting for approximately 51% of the market in 2025. Their recurring use in routine screening creates a stable revenue base for manufacturers, while instrument upgrades provide additional opportunities for technology vendors.

The market outlook remains favorable as blood centers modernize infrastructure and expand screening capabilities. Growing demand for automation, multiplex testing, molecular technologies, and connected laboratory systems is expected to create opportunities for both established diagnostic companies and emerging technology providers through 2035.

Explore key developments shaping industry transformation:

Cell Line Development Market Volume

Cell Line Development Market Forecast

Chemotherapy Market Outlook

Chemotherapy Market Analysis

Chemotherapy Market Distribution

Read More
Lukoon https://lukoon.com